The opening of new positions that didn’t exist before indicates the considerable need for the positions. Recently, Korean subsidiaries of multinational pharmaceutical companies that mainly supply new drugs have opened up two new positions - GA (Government Affairs) and PA (Patient Advocacy).

The changes seem to be in line with the trend in the new drug industry. In the era of ‘high-priced new drugs,’ the government and pharmaceutical industries are having difficulty seeing eye-to-eye when setting the drug price, and the reimbursement listing of new drugs has become the factor that determines the success or failure of a new drug.

Issues that cannot be resolved through direct communicat